Securities code: Shanghai Haohai Biological Technology Co.Ltd(688366) securities abbreviation: Shanghai Haohai Biological Technology Co.Ltd(688366) Announcement No.: 2022012 Shanghai Haohai Biological Technology Co.Ltd(688366)
Announcement of the resolution of the 20th meeting of the Fourth Board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
Shanghai Haohai Biological Technology Co.Ltd(688366) (hereinafter referred to as “the company” or ” Shanghai Haohai Biological Technology Co.Ltd(688366) “) the 20th meeting of the Fourth Board of supervisors (hereinafter referred to as “the meeting”) was held by means of communication on March 11, 2022. The notice of the meeting was sent to all supervisors of the company in writing on March 8, 2022. The meeting was presided over by Mr. Liu Yuanzhong, chairman of the board of supervisors. There were 5 supervisors who should attend the meeting and 5 supervisors who actually attended the meeting. The meeting was convened and held in accordance with the company law of the people’s Republic of China (hereinafter referred to as the “company law”) and other laws and regulations and the relevant provisions of Shanghai Haohai Biological Technology Co.Ltd(688366) articles of association.
2、 Deliberation at the meeting of the board of supervisors
After deliberation by the supervisors present at the meeting, the following resolutions are made:
1. The proposal on adjusting the first grant of the 2021 A-share restricted stock incentive plan was reviewed and approved
After review, the board of supervisors believes that the adjustment of the list of incentive objects and the number of awards granted for the first time in the 2021 A-share restricted stock incentive plan (hereinafter referred to as the “incentive plan”) complies with the company law, the securities law of the people’s Republic of China, the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “administrative measures”) and other laws and regulations The company has fulfilled the necessary procedures in accordance with the relevant provisions of the normative documents and the Shanghai Haohai Biological Technology Co.Ltd(688366) 2021 A-share restricted stock incentive plan (Draft) (hereinafter referred to as the “incentive plan (Draft)”). The adjusted incentive object is not prohibited from being granted restricted shares, and the subject qualification of the incentive object is legal and effective. This adjustment is within the scope of authorization of the company’s first extraordinary general meeting in 2022, the first A-share general meeting in 2022 and the first H-share general meeting in 2022 (hereinafter collectively referred to as “the first general meeting in 2022”), the adjustment procedure is legal and compliant, and there is no damage to the interests of the company and shareholders.
After this adjustment, the number of incentive objects granted for the first time in the incentive plan is adjusted from 206 to 204, the number of restricted shares granted for the first time is adjusted from 1.45 million shares to 1.44 million shares, the number of reserved shares is adjusted from 350000 shares to 360000 shares, and the total number of restricted shares granted remains unchanged. In addition to the above adjustments, other contents of the incentive plan are consistent with those deliberated and approved by the company’s first general meeting of shareholders in 2022.
In conclusion, the board of supervisors agreed to the proposal on adjusting matters related to the first grant of A-share restricted stock incentive plan in 2021.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement of Shanghai Haohai Biological Technology Co.Ltd(688366) on adjusting matters related to the first grant of A-share restricted stock incentive plan in 2021 (Announcement No.: 2022013)
Voting results: 4 in favor, 0 against and 0 abstention.
Supervisor Wei Changzheng avoided voting on the proposal because his spouse was the incentive object granted for the first time in the incentive plan.
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
2. The proposal on granting A-share restricted shares to the incentive objects of the 2021 A-share restricted stock incentive plan for the first time was deliberated and adopted
After review, the board of supervisors believes that the first award of this incentive plan complies with the relevant provisions of the management measures and incentive plan (Draft):
(1) The incentive plan is granted to the directors, senior managers, core technicians of the company (including subsidiaries) and other personnel deemed necessary by the board of directors for the first time (excluding Shanghai Haohai Biological Technology Co.Ltd(688366) independent directors, supervisors, shareholders or actual controllers holding more than 5% of shares alone or in total and their spouses, parents and children). The incentive objects granted for the first time in the incentive plan meet the incentive object conditions specified in the administrative measures and the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and meet the scope of incentive objects specified in the company’s incentive plan (Draft). As the incentive object granted for the first time in the incentive plan, its subject qualification is legal and effective. (2) The company and the incentive objects granted for the first time by the incentive plan have not been allowed to grant rights and interests, and the conditions for the incentive objects to be granted rights and interests set in the incentive plan have been met.
(3) The company determines that the first grant date of the incentive plan complies with the relevant provisions on the grant date in the administrative measures and the incentive plan (Draft).
Therefore, the board of supervisors agreed that the company would grant 1.44 million restricted shares to 204 incentive objects on March 11, 2022, with the grant price of 95.00 yuan / share.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The announcement of Shanghai Haohai Biological Technology Co.Ltd(688366) on granting A-share restricted shares to the incentive objects of 2021 A-share restricted stock incentive plan for the first time (Announcement No.: 2022014) disclosed.
Voting results: 4 in favor, 0 against and 0 abstention.
Supervisor Wei Changzheng avoided voting on the proposal because his spouse was the incentive object granted for the first time in the incentive plan.
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
It is hereby announced.
Shanghai Haohai Biological Technology Co.Ltd(688366) board of supervisors
March 12, 2022
